Clinical Trial Update: A Study to Evaluate the Effect of a Single-Dose Intravenous Administration of MEDI-528 [Phase 2]

View source ↗

Summary

Phase 2 study evaluating a single-dose intravenous MEDI-528 for asthma was terminated; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• MEDI-528

Snippet

Sponsor: MedImmune LLC | Conditions: Asthma | Phase 2 | Status: TERMINATED | Results posted: 2014-03-07